23 completed, 8 terminated, 7 recruiting, 6 unknown. 52 Phase 2, 11 Phase 1, 8 Phase 3.
Follow Cardiac Conduction System Disease: new trials by email Literature Review of Cardiac Conduction System Disease trials Research Report on Cardiac Conduction System Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATR 1072 in Participants With PRKAG2 Syndrome ATR 1072 - Cardiac Glycogenosis, Cardiomyopathy | Phase 1 / Phase 2 | Recruiting | Atrium Therapeutics | 37 | 2026-09-14 | 2026-09-18 |
| Using Mirabegron to Control Arrhythmia-1 Mirabegron - Ventricular Arrhythmias and Cardiac Arrest | Phase 2 | Not yet recruiting | Cedars-Sinai Medical Center | 20 | 2026-05-01 | 2026-05-06 |
| Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3) baseline lead-in, THRV-1268 - Long QT Syndrome (LQTS) 2 | Phase 2 / Phase 3 | Recruiting | Thryv Therapeutics, Inc. | 84 | 2026-03-07 | 2026-09-21 |
| Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) AGP100 - Catecholaminergic Polymorphic Ventricular Tachycardia | Phase 2 | Recruiting | Agiana Pharmaceuticals | 10 | 2026-01-02 | 2025-12-26 |
| A Phase 2 Study of CRD-4730 in CPVT CRD-4730, Placebo - Catecholaminergic Polymorphic Ventricular Tachycardia | Phase 2 | Recruiting | Cardurion Pharmaceuticals, Inc. | 12 | 2025-12-01 | 2026-07-09 |
| Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome Empagliflozin (EMPA) - Brugada Syndrome (BrS) | Phase 2 | Not yet recruiting | National Taiwan University Hospital | 10 | 2025-09-15 | 2025-09-12 |
| To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU. Placebo drug ( normal saline ), neostigmine (reversal agent) - Tachycardia, Hypertension | Phase 1 / Phase 2 | Completed | Ziauddin University | 100 | 2025-03-12 | 2025-07-31 |
| N-of-1 in ATS and MEPPC Flecainide, Flecainide + beta-blocker - Andersen Tawil Syndrome, Multifocal Ectopic Purkinje-related Premature Contractions | Phase 2 | Not yet recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 10 | 2025-03-01 | 2025-01-29 |
| Efficacy of Varenicline Tartrate in Treating Frequent Premature Ventricular Contractions Varenicline Tartrate Tablets, Placebo - Premature Ventricular Contraction (PVC) | Phase 2 | Completed | Yihan Chen | 116 | 2025-02-17 | 2025-11-19 |
| Efficacy and Safety of memanTine in the Treatment Of Frequently symPtomatic Atrial Premature Beats Memantine Hydrochloride 10 MG, Placebo - Atrial Premature Beats, Contractions, or Systoles | Phase 2 | Completed | Shanghai East Hospital | 256 | 2024-08-29 | 2025-11-25 |
| The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) Etripamil NS - Paroxysmal Supraventricular Tachycardia | Phase 2 | Recruiting | Milestone Pharmaceuticals Inc. | 60 | 2023-12-11 | 2026-07-21 |
| Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) CRD-4730, Placebo - CPVT1, Heart Defects, Congenital | Phase 2 | Terminated | Cardurion Pharmaceuticals, Inc. | 7 | 2023-11-07 | 2026-05-27 |
| Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT) stereotactic body radiotherapy, 20 Gy in 1 fraction - Ventricular Tachycardia, Arrhythmia | Phase 2 | Enrolling by invitation | McGill University Health Centre/Research Institute of the McGill University Health Centre | 9 | 2023-07-01 | 2025-03-18 |
| StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2 Stereotactic Arrhythmia Radiotherapy - Ventricular Tachycardia, Arrythmia, Cardiac | Phase 2 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 12 | 2023-05-19 | 2026-01-14 |
| Comparison of IV Lignocain and IV Dexmedetomidine for Attenuation of Laryngoscopic Stress Response to Direct Laryngoscopy Intravenous Dexmedetomidine infusion, Intravenous Lignocain - Tachycardia, Hypertension | Phase 2 / Phase 3 | Completed | Shaheed Mohtarma Benazir Bhutto Institue of Trauma | 62 | 2023-04-13 | 2026-02-03 |
| Venous Ethanol for Ventricular Tachycardia Venous ethanol, Catheter ablation - Ventricular Tachycardia, Ischemic Cardiomyopathy | Phase 2 | Recruiting | The Methodist Hospital Research Institute | 156 | 2023-04-12 | 2026-07-24 |
| Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2). LQT-1213, Placebo, Dofetilide 250 μg Cap - Long QT Syndrome | Phase 1 / Phase 2 | Terminated | Thryv Therapeutics, Inc. | 42 | 2023-03-12 | 2025-07-24 |
| SBRT in Chagas Disease Ventricular Tachycardia Stereotactic Body Radiation Therapy - Ventricular Tachycardia, Chagas Disease | Phase 1 / Phase 2 | Unknown | University of Sao Paulo General Hospital | 10 | 2021-07-14 | 2024-07-16 |
| Mutation-specific Therapy for the Long QT Syndrome Lumacaftor / Ivacaftor, Orkambi® Oral Tablet - Long QT Syndrome | Phase 2 | Completed | Istituto Auxologico Italiano | 16 | 2021-06-15 | 2025-04-25 |
| Specialized Pacing for Patients With Congenital Heart Disease Closed loop stimulation, Standard rate response - Congenital Heart Disease, Bradycardia Sinus | Phase 2 / Phase 3 | Terminated | University of California, Los Angeles | 4 | 2021-05-09 | 2023-01-20 |
Showing 20 of 52. Sign in to see all of them.
Tachycardia, Ventricular (20) · Arrhythmias, Cardiac (11) · Tachycardia (10) · Ventricular Fibrillation (7) · Long QT Syndrome (6) · Ventricular Premature Complexes (5) · Death, Sudden, Cardiac (4) · Atrial Fibrillation (3) · Brugada Syndrome (3) · Hypertension (3) · Atrial Premature Complexes (2) · Cardiomyopathies (2) · Heart Arrest (2) · Heart Defects, Congenital (2) · Heart Diseases (2)
Cardiovascular Diseases (52) · Pathological Conditions, Signs and Symptoms (51) · Heart Diseases (50) · Pathologic Processes (50) · Arrhythmias, Cardiac (41) · Tachycardia (23) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14) · Cardiovascular Abnormalities (11) · Congenital Abnormalities (11) · Heart Defects, Congenital (9) · Cardiac Complexes, Premature (7) · Vascular Diseases (6) · Death (5) · Death, Sudden (4)
Radiosurgery (3) · Ranolazine (3) · Saline Solution (3) · Sodium Chloride (3) · Adrenergic beta-Antagonists (2) · Catheter Ablation (2) · Flecainide (2) · Memantine (2) · esmolol (2) · Acetazolamide (1) · Ajmaline (1) · Atenolol (1) · Atomoxetine Hydrochloride (1) · Capsules (1) · Cardiac Resynchronization Therapy (1)
Aalborg University Hospital (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Beth Israel Deaconess Medical Center (2) · Boston Scientific Corporation (2) · Cardurion Pharmaceuticals, Inc. (2) · Milestone Pharmaceuticals Inc. (2) · Thryv Therapeutics, Inc. (2) · Agiana Pharmaceuticals (1) · Andrea Morelli (1) · AtriCure, Inc. (1) · Atrium Therapeutics (1) · Biosense Webster, Inc. (1) · Cedars-Sinai Medical Center (1) · Centre Hospitalier Universitaire, Amiens (1) · Chiang Mai University (1)
United States (26) · Canada (7) · Italy (6) · Germany (5) · Netherlands (5) · Denmark (4) · Czechia (3) · France (3) · Israel (3) · Spain (3) · China (2) · Pakistan (2) · Belgium (1) · Brazil (1) · Hungary (1)
Alvaro Alonso, MD PhD (1) · Andrea Morelli, MD (1) · Asma Abdus Salam, Consultant anaesthesiology (1) · Chester M Hedgepeth, MD, PhD (1) · David Bharucha, MD (1) · David E Haines, MD (1) · Eli Gang, MD (1) · Elijah Behr, MD (1) · Francis Plat (1) · Henning R Andersen, MD, DMSc (1) · James E Tisdale, BSc, PharmD (1) · James Edgerton, MD (1)
PMID 10492412, PMID 10793602, PMID 12717123, PMID 1356374, PMID 14563591, PMID 15911704, PMID 17893459, PMID 19687359, PMID 20576632, PMID 21300730, PMID 21978965, PMID 22091288, PMID 22106360, PMID 23372884, PMID 23449923, PMID 23983684, PMID 24002370, PMID 24108526, PMID 24227635, PMID 24495468, PMID 24606242, PMID 24721800, PMID 27733495, PMID 29261883, PMID 30049309, PMID 30573962, PMID 30586734, PMID 32517192, PMID 32673517, PMID 34667360, PMID 35066509, PMID 3605668, PMID 37139057, PMID 40894163, PMID 41778949, PMID 41853846, PMID 42402640, PMID 6161627, PMID 9366929, PMID 9793671, PMID 9797517
2016 (1), 2025 (1), R01HL059459 (1), R01HL061682 (1), UL1TR000445 (1)